A485 may enhance the efficacy of anti-PD-L1 antibody treatment, reducing the PD-L1 expression and exosomal secretion by PC cell lines; combined treatments inhibited the androgen-independent metastatic tumor growth in syngeneic PC models [116]. This evidence concerns the gene CD274 and neoplasm.